DeviceClearance

EUROIMMUN Anti-tissue Transglutaminase ELISA (IgA), EUROIMMUN Anti-tissue Transglutaminase ELISA (IgG)— 510(k) K183313

Substantially Equivalent

Euroimmun Us, Inc.

FDA 510(k) clearance K183313 for EUROIMMUN Anti-tissue Transglutaminase ELISA (IgA), EUROIMMUN Anti-tissue Transglutaminase ELISA (IgG), Substantially Equivalent on 2019-02-28. Applicant: Euroimmun Us, Inc..

Clearance details

Applicant
Euroimmun Us, Inc.
Product code
Code MVM
Advisory panel
Immunology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Mountain Lakes, NJ, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.